TransMedics Group, Inc. (TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	5,077	4,157	2,093	2,577	1,970	532
Market Cap Growth	112.39%	98.67%	-18.80%	30.78%	270.34%	-1.57%
Enterprise Value	5,108	4,210	2,281	2,665	1,834	464
Last Close Price	148.00	121.65	62.35	78.93	61.72	19.16
PE Ratio	30.37	21.85	59.01	-	-	-
Forward PE	59.23	47.40	56.70	-	-	-
PS Ratio	8.38	6.87	4.74	10.67	21.08	17.58
PB Ratio	10.72	8.79	9.15	18.78	10.52	7.84
P/TBV Ratio	11.05	9.05	9.74	20.97	10.52	7.84
P/FCF Ratio	38.00	31.12	-	-	-	-
P/OCF Ratio	26.33	21.56	42.88	-	-	-
EV/Sales Ratio	8.44	6.95	5.17	11.03	19.62	15.34
EV/EBITDA Ratio	37.98	31.31	39.83	400.09	-	-
EV/EBIT Ratio	47.04	38.78	60.82	-	-	-
EV/FCF Ratio	38.23	31.52	-	-	-	-
Debt / Equity Ratio	1.10	1.10	2.27	3.76	0.36	0.65
Debt / EBITDA Ratio	3.65	3.65	8.19	45.04	-	-
Debt / FCF Ratio	3.89	3.89	-	-	-	-
Net Debt / Equity Ratio	0.07	0.07	0.80	0.88	-0.71	-0.72
Net Debt / EBITDA Ratio	0.23	0.23	3.17	18.18	4.78	1.29
Net Debt / FCF Ratio	0.23	0.23	-2.24	-0.73	2.32	1.50
Asset Turnover	0.65	0.65	0.59	0.49	0.45	0.21
Inventory Turnover	5.09	5.09	3.95	2.70	1.59	0.68
Quick Ratio	6.41	6.41	7.25	8.34	9.67	4.23
Current Ratio	7.14	7.14	8.30	9.30	10.66	5.11
Return on Equity (ROE)	54.24%	54.24%	19.39%	-15.42%	-28.39%	-51.49%
Return on Assets (ROA)	7.25%	7.25%	3.10%	-0.19%	-9.54%	-17.18%
Return on Invested Capital (ROIC)	23.80%	23.75%	11.12%	-0.97%	-86.19%	-245.59%
Return on Capital Employed (ROCE)	11.10%	11.10%	5.00%	-0.20%	-12.40%	-35.30%
Earnings Yield	3.75%	4.58%	1.70%	-0.97%	-1.84%	-8.31%
FCF Yield	2.63%	3.21%	-3.87%	-6.40%	-2.93%	-6.09%
Buyback Yield / Dilution	-15.12%	-15.12%	-8.30%	-10.02%	-7.02%	-11.80%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q